Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury

被引:0
|
作者
Zhao-Yang Wang [1 ]
Yu Liu [2 ]
Shi-Peng Li [3 ]
Jian-Jun Li [1 ]
Zhen Zhang [4 ]
Xue-Chun Xiao [1 ]
Yang Ou [1 ]
Hang Wang [1 ]
Jin-Zhen Cai [5 ]
Shuang Yang [6 ]
机构
[1] Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation,Medical College of Nankai University
[2] Department of Internal Medicine,Wangdingdi Hospital
[3] Liver Transplant Center of Beijing Friendship Hospital,Capital Medical University
[4] Institute of Clinical Medicine,Jiangxi Provincial People’s Hospital Affiliated to Nanchang University
[5] Organ Transplantation Center,Affiliated Hospital of Qingdao University
[6] Institute of Transplantation Medicine,Tianjin First Central Hospital,Nankai University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Ischemia-reperfusion injury(IRI) is a major risk associated with liver surgery and transplantation,and its pathological mechanism is complex.Interleukin-1 receptor antagonist(IL-1ra) can protect the liver from IRI.However,the regulatory mechanism of IL-1ra expression is still unclear.AIM To identify the mechanism that could protect the liver in the early stage of IRI.METHODS To screen the key genes in hepatic IRI,we performed RNA sequencing and gene enrichment analysis on liver tissue from mice with hepatic IRI.Subsequently,we verified the expression and effect of IL-1ra in hepatic IRI.We also used promoter mutagenesis and chromatin immunoprecipitation assay to search for the transcriptional regulatory sites of hypoxia-inducible factor(HIF)-1α.Finally,to explore the protective mechanism of ischemic preconditioning(IP),we examined the expression of HIF-1α and IL-1ra after IP.RESULTS We identified IL-1ra as a key regulator in hepatic IRI.The expression of IL-1ra was significantly upregulated after hepatic IRI both in vivo and in vitro.Furthermore,we found that HIF-1αregulated Il-1ra transcription in response to hypoxia.Increased HIF-1α accumulation promoted IL-1ra expression,whereas inhibition of HIF-1α exhibited the opposite effect.We also confirmed a predominant role for hypoxia response element in the regulation of Il1ra transcription by HIF-1αactivation.Of note,we demonstrated that IP protects against hepatic IRI by inducing IL-1ra expression,which is mediated through HIF-1α.CONCLUSION We demonstrated that ischemia or hypoxia leads to increased expression of IL-1ra through HIF-1α.Importantly,IP protects the liver from IRI via the HIF-1α–IL-1ra pathway.
引用
收藏
页码:5573 / 5588
页数:16
相关论文
共 50 条
  • [1] Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury
    Wang, Zhao-Yang
    Liu, Yu
    Li, Shi-Peng
    Li, Jian-Jun
    Zhang, Zhen
    Xiao, Xue-Chun
    Ou, Yang
    Wang, Hang
    Cai, Jin-Zhen
    Yang, Shuang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (38) : 5573 - 5588
  • [2] Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury
    Rusai, Krisztina
    Huang, Hai
    Sayed, Nora
    Strobl, Matthias
    Roos, Marcel
    Schmaderer, Christoph
    Heemann, Uwe
    Lutz, Jens
    TRANSPLANT INTERNATIONAL, 2008, 21 (06) : 572 - 580
  • [3] Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury
    Harada, H
    Wakabayashi, G
    Takayanagi, A
    Shimazu, M
    Matsumoto, K
    Obara, H
    Shimizu, N
    Kitajima, M
    TRANSPLANTATION, 2002, 74 (10) : 1434 - 1441
  • [4] The interleukin-1 receptor antagonist anakinra protects from renal ischemia-reperfusion injury
    Rusai, Krisztina
    Huang, Hai
    Syed, Nora
    Strobl, Matthias
    Roos, Marcel
    Schmaderer, Christoph
    Heemann, Uwe
    Lutz, Jens
    TRANSPLANT INTERNATIONAL, 2007, 20 : 215 - 215
  • [5] Administration of interleukin-1 receptor antagonist (IL-1ra) ameliorates ischemia-reperfusion injury of the kidney
    Rusai, K.
    Huang, H.
    Sayed, N.
    Strobl, M.
    Roos, M.
    Schmaderer, C.
    Heemann, U.
    Lutz, J.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1452 - 1452
  • [6] INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN (IRAP) DOES NOT PREVENT HEPATIC ISCHEMIA REPERFUSION INDUCED INJURY
    MCCURRY, KR
    CAMPBELL, DA
    TRACEY, DE
    HOWATT, MA
    REMICK, DG
    FASEB JOURNAL, 1992, 6 (04): : A1026 - A1026
  • [7] Interleukin-1 in ischemia-reperfusion acute lung injury
    Chang, DM
    Hsu, K
    Ding, YA
    Chiang, CH
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (04) : 1230 - 1234
  • [8] Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia-reperfusion injury
    Zhu, Jinzhou
    Huang, Jiannan
    Dai, Daopeng
    Wang, Xia
    Gao, Jing
    Han, Wei
    Zhang, Ruiyan
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 1 - 5
  • [9] Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis
    Suzuki, K
    Murtuza, B
    Smolenski, RT
    Sammut, IA
    Suzuki, N
    Kaneda, Y
    Yacoub, MH
    CIRCULATION, 2001, 104 (12) : I308 - I313
  • [10] Impact of an Interleukin-1 Receptor Antagonist and Erythropoietin on Experimental Myocardial Ischemia/Reperfusion Injury
    Grothusen, Christina
    Hagemann, Angelika
    Attmann, Tim
    Braesen, Jan
    Broch, Ole
    Cremer, Jochen
    Schoettler, Jan
    SCIENTIFIC WORLD JOURNAL, 2012,